Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study.

Circ Genom Precis Med · 2025 · PMC7617573 · PMID 40052268

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

nominally significantP <0.05actually significant

The association was deemed to be statistically robust to pleiotropy when estimates were directionally consistent and nominally significant (P <0.05) across all methods.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.